Swinburne medical cannabis driving trial starts
Swinburne is leading a trial as part of the Victorian Government’s $4.9 million investment in developing an informed position on medicinal cannabis and drug driving.
In summary
- The Allan Labor Government’s closed-circuit trial to investigate whether individuals who use medicinal cannabis can drive safely has begun.
- The 18-month trial conducted by Swinburne will assist in understanding how THC in medicinal cannabis impacts driving performance.
- Minister for Roads and Road Safety Melissa Horne has announced the world first trial kicked off at METEC Driver Training in Bayswater.
The first drive has taken place on the Victoria Government’s closed-circuit trial to investigate whether individuals who use medicinal cannabis can drive safely.
Minister for Roads and Road Safety Melissa Horne has announced the world first trial kicked off at METEC Driver Training in Bayswater.
Backed by a $4.9 million investment by the Government – the 18-month trial conducted by Swinburne University of Technology, will assist in understanding how THC in medicinal cannabis impacts driving performance and how this translates into risk on the road – with a regional trial track set to also begin in Anglesea.
Lead Researcher of Swinburne's Drugs and Driving Research Unit Professor Luke Downey says, "We've made significant strides in the articulation of our research vehicles, which are specifically designed to assess driving performance in real-world conditions".
Researchers will review participants’ ability to manage distractions and assess their driving performance including steering, braking and speed control.
The drivers will also be closely monitored throughout the trial and strict protections will be in place to make sure people at the track keep safe.
A qualified driving instructor will be present in the vehicle at all phases of the driving assessments, with access to dual controls to intervene promptly if needed.
The private driving course mirrors real-world conditions and is away from public roads.
To qualify, participants must have been prescribed medicinal cannabis for a sleep disorder, chronic pain, or a mental health condition for at least six months. The trial will include pre and post-drive drug impairment screenings.
Minister for Roads and Road Safety Melissa Horne says, “In a world first trial, we have kicked off the first drive to gain a greater understanding on the effects of medicinal cannabis on driving in Victoria".
To learn more about the track trial, visit the trial website.
-
Media Enquiries
Related articles
-
- Business
- Technology
Startups lead the way in innovation at 2024 Venture Cup Pitch Night
The 2024 Annual Venture Cup Pitch Night at Swinburne University of Technology celebrated the achievements of seven startups, marking the successful completion of their journey through Swinburne Innovation Studio's accelerator initiative, the Elevate Program.
Monday 02 December 2024 -
- Health
Swinburne medical cannabis driving trial starts
Swinburne is leading a trial as part of the Victorian Government’s $4.9 million investment in developing an informed position on medicinal cannabis and drug driving.
Monday 04 November 2024 -
- Technology
- Health
- Business
From custom-fit Hearables to dental devices: how H3D led a Swinburne alum to startup success
Swinburne alum Dr Philip Kinsella, co-founder and CTO of custom-fit devices startup H3D, shares the story of the company’s growth and evolution as a multi-industry innovator.
Tuesday 01 October 2024 -
- Health
Young Australians turning to social media for sexual and reproductive health support, report reveals
A new Swinburne report had found that social media is helping fill gaps in sex education and providing an essential connection point to health services for young adults.
Tuesday 08 October 2024 -
- Science
New program to set national standards for radiotherapy treatment means better health outcomes of one million Australians
Swinburne, CSIRO, and the Australian Radiation Protection and Nuclear Safety Agency have partnered on a new program to develop the next generation of national standards for radiotherapy treatment in Australia.
Tuesday 24 September 2024